Quick Answer
Quince Therapeutics, Inc. reported Total Assets of $114.48 million for fiscal year 2024.
Quince Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $114.48M | -31.8% |
| 2023 | $167.90M | +61.6% |
| 2022 | $103.91M | -22.0% |
| 2021 | $133.23M | -29.7% |
| 2020 | $189.47M | +52.3% |
| 2019 | $124.37M | +70.7% |
| 2018 | $72.88M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $109.90M | -13.1% | -6.2% |
| June 30, 2025 | $117.21M | -13.1% | +9.5% |
| March 31, 2025 | $107.09M | -32.8% | -6.5% |
| December 31, 2024 | $114.48M | -31.8% | -9.5% |
| September 30, 2024 | $126.52M | +48.2% | -6.2% |
| June 30, 2024 | $134.83M | +51.8% | -15.4% |
| March 31, 2024 | $159.29M | +70.7% | -5.1% |
| December 31, 2023 | $167.90M | +61.6% | +96.6% |
- Quince Therapeutics, Inc. showed a decrease of -31.8% in Total Assets compared to the prior fiscal year.
- Over the 2018–2024 period, Quince Therapeutics, Inc.’s total assets has grown by 57.1% (from $72.88 million to $114.48 million).
- The most recent figure is from Quince Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: